ctrl K

Keros Therapeutics Inc. (KROS)

NASDAQ: KROS · Real-Time Price · USD

14.64

0.07 (0.48%)

At close: May 02, 2025, 3:59 PM

14.65

0.07%

After-hours: May 02, 2025, 04:40 PM EDT

Keros Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	3.55M	151K	n/a	20.1M	n/a	10M	10M
Cost of Revenue	1.23M	815K	1.61M	898K	605K	17.35M	10.11M
Gross Profit	2.32M	-664K	-1.61M	19.2M	-605K	-7.35M	-111K
Operating Income	-210.83M	-169.94M	-114.79M	-56.37M	-46.66M	-10.56M	-1.69M
Interest Income	n/a	n/a	1K	4K	6K	8K	6K
Pretax Income	-187.05M	-152.99M	-104.68M	-56.73M	-45.53M	-12.34M	-1.08M
Net Income	-187.35M	-152.99M	-104.68M	-58.74M	-45.36M	-12.34M	-1.33M
Selling & General & Admin	40.75M	34.83M	27.52M	21.33M	12.8M	3.18M	1.58M
Research & Development	173.63M	135.26M	87.27M	55.14M	33.86M	17.38M	10.11M
Other Expenses	n/a	n/a	-7.08M	-356K	-2.46M	-558K	237K
Operating Expenses	214.38M	170.09M	107.71M	76.47M	44.2M	20M	11.32M
Interest Expense	n/a	n/a	1K	4K	6K	8K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	214.38M	170.09M	107.71M	76.47M	44.2M	20M	11.32M
Income Tax Expense	300K	n/a	1K	2.01M	-172K	8K	257K
Shares Outstanding (Basic)	37.44M	29.45M	25.24M	23.33M	15.51M	8.88M	8.88M
Shares Outstanding (Diluted)	37.44M	29.45M	25.24M	23.33M	15.51M	8.88M	8.88M
EPS (Basic)	-5	-5.2	-4.15	-2.52	-2.93	-1.39	-0.15
EPS (Diluted)	-5	-5.2	-4.15	-2.52	-2.93	-1.39	-0.15
EBITDA	-185.82M	-152.18M	-103.06M	-56.37M	-44.92M	-11.89M	-774K
EBIT	-187.05M	-152.99M	-104.68M	-56.73M	-45.53M	-12.33M	-1.32M
Depreciation & Amortization	1.23M	815K	1.61M	898K	605K	438K	304K